AB0795 Long-term efficacy and safety of rituximab in systemic sclerosis refractory to conventional immunosuppressants

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1530 [Peer Reviewed Journal]

2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2018 © 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-eular.7061

Full text available